GLUSENSE LTD. Patent applications |
Patent application number | Title | Published |
20150343093 | CONTROLLED DEATH OF IMPLANTED CELLS - A method is provided, including implanting a chamber containing cells in a subject, and subsequently administering, to the subject, a drug capable of killing the cells. For example, the drug may be administered after the cells cease to function for their intended purpose, or if the cells escape from the implanted chamber. Alternatively, the drug may be administered to kill the cells while the cells are in the implanted chamber. Other embodiments are also described. | 12-03-2015 |
20130006069 | IMPLANTABLE OPTICAL GLUCOSE SENSING - Apparatus is provided for detecting an analyte, configured to be implanted in a body of a subject. The apparatus includes an optical fiber having a distal portion and also a membrane permeable to the analyte. The membrane is coupled to the distal portion of the fiber and surrounding a sampling region at least in part, by being fitted over the distal portion of the fiber. Other embodiments are also described. | 01-03-2013 |
20120059232 | IMPLANTABLE OPTICAL GLUCOSE SENSING - Apparatus is provided, including a support ( | 03-08-2012 |
20100160749 | IMPLANTABLE OPTICAL GLUCOSE SENSING - Apparatus is provided, including a support configured to be implanted within a body of a subject and a sampling region coupled to the support. The apparatus is configured to passively allow passage through the sampling region of at least a portion of fluid from the subject. The apparatus also comprises an optical measuring device in optical communication with the sampling region. The optical measuring device comprises at least one light source configured to transmit light through at least a portion of the fluid, and at least one sensor configured to measure a parameter of the fluid by detecting light passing through the fluid. Other embodiments are also described. | 06-24-2010 |